Helping advisers explain the role of Pharmac to potential health insurance clients is a commentary published by Partners Life.
While plenty of treatments are funded by the government agency, many are not, particularly some newer ones such as Keytruda, a lung cancer treatment that Pharmac said it would fund and then decided not to – leaving 1,400 suffers in New Zealand to find ways of paying for it themselves according to Radio New Zealand.
General Manager of Product at Partners Life, Steve Wright, says: “Health Insurance is indeed probably the most important type of insurance for protecting against unfunded drug treatments, as long as the right product is chosen.
“There are health insurance products available that don’t cover drugs not funded by Pharmac, either at all or sufficiently to cover a possible six figure expense.”
Read the full feature here.